# PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy

> **NCT06522932** · PHASE1 · RECRUITING · sponsor: **Michael Randall** · enrollment: 32 (estimated)

## Conditions studied

- Non Hodgkin Lymphoma

## Interventions

- **DRUG:** 64Cu-GRIP B
- **PROCEDURE:** Positron Emission Tomography (PET)
- **PROCEDURE:** Optional tumor biopsy

## Key facts

- **NCT ID:** NCT06522932
- **Lead sponsor:** Michael Randall
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-23
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06522932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06522932, "PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06522932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*